Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Annaly Capital

Seagate Technology Holdings PLC

AT&T

Valero Energy

The COVID-19 pandemic shaved roughly 40% from equity prices between mid-February and late March of this year.

5 Sky-High Dividend Stocks With More Upside Ahead

Disney

These stocks are trading at bargain prices, but they look poised to bounce back.

2 Value Stocks to Buy in August

Philip Morris

Altria Vs. Philip Morris: And The Winner Is.

Cerner

The end-of-month (EOM) period of strength runs from July 30 to August 4.

Stocks This Week: Sell Short Altria And Cerner

Boyd Gaming

Diageo

DraftKings

Sturm, Ruger & Company

Sin stocks tend to perform well in good times and bad. However the unique nature of the novel coronavirus is rewarding some vices more than others.

5 Sin Stocks to Gamble On

Juul Labs Inc said on Thursday it submitted an application to the U.S. Food and Drug Administration that would allow it to keep selling e-cigarettes, which face heightened scrutiny over a surge in teenage vaping.

Juul submits application to FDA to keep selling e-cigarettes

British American Tobacco

It's only the third time an e-cigarette company has attempted to make it through the regulatory morass.

Juul Labs Submits E-Cig Pre-Marketing Application to FDA

Coca-Cola

Sysco

Molson Coors Brewing

Tyson Foods

Walgreens

The COVID-19 pandemic has affected the stocks that comprise the S&P 500 consumer staples sectors differently.

Can These 8 S&P Consumer Staples Stocks Make a Comeback?

Verizon

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

Which income stock offers more safety in this volatile market?

Better Dividend Buy: Verizon Communications vs. Altria

Altria stock increased around 36% since the late March lows (vs. about 44% for S&P 500) to its current level of $43.

Altria: A Good Defensive Bet Right Now?

Altria: Raising Estimates After Q2; 8% Dividend Yield And 10x P/E

Altria Group, Inc. (MO) CEO Billy Gifford on Q2 2020 Results - Earnings Call Transcript

The Philip Morris owner saw lower sales in smokable products.

Altria Group Reports Lower Revenue in the Second Quarter, Declares Dividend Raise

Altria's (MO) second-quarter 2020 results reflect adjusted OCI growth in oral tobacco and smokeable product segments. However, smokeable product revenues decline.

Altria's (MO) Q2 Earnings Beat Estimates, Revenues Down Y/Y

Altria Group Inc. (NYSE: MO) reported its most recent quarterly results before the markets opened on Tuesday.

Altria Q2 Earnings Are Smoking

Altria earnings have MO stock jumping higher on Tuesday after the company beat EPS and revenue expectations from Wall Street for the quarter.
The post Altria Earnings: MO Stock Rises on Q2 Beats, Excellent EPS Guidance appeared first on InvestorPlace.

Altria Earnings: MO Stock Rises on Q2 Beats, Excellent EPS Guidance

Shares of Altria Group (NYSE:MO) rose 0.6% after the company reported Q2 results.

Recap: Altria Group Q2 Earnings

Altria (MO) delivered earnings and revenue surprises of 2.83% and -0.24%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Altria (MO) Surpasses Q2 Earnings Estimates

Shares of Altria Group Inc. MO, +0.66% edged up 0.5% in premarket trading Tuesday, after the parent of Marlboro and Skoal tobacco products reported a second-quarter profit that beat expectations but revenue that missed, while raising its quarterly dividend.

Altria's stock gains after profit beat and dividend hike, while revenue missed

Marlboro maker Altria said it expected full-year earnings to rise as much as 4% from last year and announced plans to expand the availability of its iQOS heated-tobacco devices in more markets in the U.S.

Marlboro maker Altria expects higher earnings in 2020

RICHMOND, Va.--(BUSINESS WIRE)-- #FYguidance--Altria Reports 2020 Second-Quarter and First-Half Results; Reestablishes 2020 Full-Year Earnings Guidance

Altria Reports 2020 Second Quarter and First-Half Results; Reestablishes 2020 Full-Year Earnings Guidance; Announces IQOS Expansion Plans; Board Declares Dividend Increase

The tobacco giant reports earnings tomorrow morning, and an ascending triangle pattern suggests that the stock is poised for a big move.

Altria Stock Set to Pop or Drop by 20%

Why Investors Should Hold Altria For The 8% Dividend Yield

Enterprise Products Partners

Interpublic Group of Companies

iShares Russell 2000 ETF

Unum

Vale S.A.

Vodafone Group

Looking to build a long-term portfolio? Here are seven of the best dividend-paying stocks.

The 7 Best Dividend Stocks for Adventurous Investors

Ford Motor Company

General Electric

Starbucks

Over the past few months, we’ve seen an absolute roller-coaster of volatility in the markets, followed by a solid recovery, all due to the coronavirus pandemic.

News for Altria Stock (MO)